nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—CYP1A1—head and neck cancer	0.366	1	CbGaD
Albendazole—TUBA1A—Vinblastine—head and neck cancer	0.319	0.553	CbGbCtD
Albendazole—TUBB4B—Vinblastine—head and neck cancer	0.122	0.211	CbGbCtD
Albendazole—TUBB4B—Docetaxel—head and neck cancer	0.1	0.174	CbGbCtD
Albendazole—TUBA1A—superior cervical ganglion—head and neck cancer	0.0119	0.358	CbGeAlD
Albendazole—CYP1A2—Fluorouracil—head and neck cancer	0.0107	0.0185	CbGbCtD
Albendazole—ABCB1—Vinblastine—head and neck cancer	0.00868	0.015	CbGbCtD
Albendazole—ABCB1—Docetaxel—head and neck cancer	0.00715	0.0124	CbGbCtD
Albendazole—CYP3A4—Vinblastine—head and neck cancer	0.0052	0.009	CbGbCtD
Albendazole—CYP3A4—Docetaxel—head and neck cancer	0.00429	0.00742	CbGbCtD
Albendazole—TUBA1A—hair follicle—head and neck cancer	0.00206	0.0618	CbGeAlD
Albendazole—Mebendazole—CYP1A1—head and neck cancer	0.00178	1	CrCbGaD
Albendazole—TUBA1A—mouth—head and neck cancer	0.00162	0.0485	CbGeAlD
Albendazole—TUBA1A—neck—head and neck cancer	0.00138	0.0415	CbGeAlD
Albendazole—TUBB4B—hair follicle—head and neck cancer	0.00137	0.0412	CbGeAlD
Albendazole—TUBA1A—parotid gland—head and neck cancer	0.00112	0.0338	CbGeAlD
Albendazole—TUBA1A—saliva-secreting gland—head and neck cancer	0.00108	0.0324	CbGeAlD
Albendazole—TUBA1A—connective tissue—head and neck cancer	0.00099	0.0297	CbGeAlD
Albendazole—TUBA1A—epithelium—head and neck cancer	0.00094	0.0282	CbGeAlD
Albendazole—TUBA1A—trachea—head and neck cancer	0.000831	0.025	CbGeAlD
Albendazole—TUBB4B—parotid gland—head and neck cancer	0.00075	0.0225	CbGeAlD
Albendazole—TUBA1A—lymphoid tissue—head and neck cancer	0.000724	0.0217	CbGeAlD
Albendazole—TUBB4B—saliva-secreting gland—head and neck cancer	0.000718	0.0216	CbGeAlD
Albendazole—TUBB4B—connective tissue—head and neck cancer	0.00066	0.0198	CbGeAlD
Albendazole—TUBA1A—thyroid gland—head and neck cancer	0.000657	0.0197	CbGeAlD
Albendazole—CYP1A1—mouth—head and neck cancer	0.000603	0.0181	CbGeAlD
Albendazole—TUBA1A—head—head and neck cancer	0.000583	0.0175	CbGeAlD
Albendazole—CYP1A2—Arylamine metabolism—NAT2—head and neck cancer	0.000572	0.0563	CbGpPWpGaD
Albendazole—TUBB4B—trachea—head and neck cancer	0.000554	0.0166	CbGeAlD
Albendazole—TUBB4B—lymphoid tissue—head and neck cancer	0.000482	0.0145	CbGeAlD
Albendazole—TUBB4B—thyroid gland—head and neck cancer	0.000438	0.0132	CbGeAlD
Albendazole—Renal failure acute—Hydroxyurea—head and neck cancer	0.000434	0.0399	CcSEcCtD
Albendazole—CYP1A1—parotid gland—head and neck cancer	0.00042	0.0126	CbGeAlD
Albendazole—TUBA1A—p73 transcription factor network—RAD51—head and neck cancer	0.000413	0.0407	CbGpPWpGaD
Albendazole—TUBA1A—p73 transcription factor network—YAP1—head and neck cancer	0.000413	0.0407	CbGpPWpGaD
Albendazole—TUBA1A—lymph node—head and neck cancer	0.000408	0.0123	CbGeAlD
Albendazole—TUBB4B—head—head and neck cancer	0.000389	0.0117	CbGeAlD
Albendazole—TUBA1A—G2/M Transition—CCNA1—head and neck cancer	0.000386	0.038	CbGpPWpGaD
Albendazole—TUBA1A—Mitotic G2-G2/M phases—CCNA1—head and neck cancer	0.000381	0.0375	CbGpPWpGaD
Albendazole—Pancytopenia—Vinblastine—head and neck cancer	0.00036	0.0332	CcSEcCtD
Albendazole—CYP1A1—epithelium—head and neck cancer	0.000351	0.0105	CbGeAlD
Albendazole—Pancytopenia—Hydroxyurea—head and neck cancer	0.000329	0.0303	CcSEcCtD
Albendazole—Neutropenia—Hydroxyurea—head and neck cancer	0.000324	0.0298	CcSEcCtD
Albendazole—Agranulocytosis—Vinblastine—head and neck cancer	0.000316	0.0291	CcSEcCtD
Albendazole—CYP1A1—trachea—head and neck cancer	0.00031	0.00932	CbGeAlD
Albendazole—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000292	0.0269	CcSEcCtD
Albendazole—TUBB4B—lymph node—head and neck cancer	0.000272	0.00818	CbGeAlD
Albendazole—Alopecia—Vinblastine—head and neck cancer	0.000268	0.0247	CcSEcCtD
Albendazole—CYP1A2—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00025	0.0246	CbGpPWpGaD
Albendazole—CYP1A2—thyroid gland—head and neck cancer	0.000249	0.00747	CbGeAlD
Albendazole—CYP1A1—thyroid gland—head and neck cancer	0.000245	0.00737	CbGeAlD
Albendazole—Alopecia—Hydroxyurea—head and neck cancer	0.000245	0.0225	CcSEcCtD
Albendazole—Vertigo—Vinblastine—head and neck cancer	0.000238	0.0219	CcSEcCtD
Albendazole—Leukopenia—Vinblastine—head and neck cancer	0.000237	0.0218	CcSEcCtD
Albendazole—Pancytopenia—Fluorouracil—head and neck cancer	0.000237	0.0218	CcSEcCtD
Albendazole—TUBB4B—G2/M Transition—CCNA1—head and neck cancer	0.000233	0.0229	CbGpPWpGaD
Albendazole—TUBB4B—Mitotic G2-G2/M phases—CCNA1—head and neck cancer	0.00023	0.0226	CbGpPWpGaD
Albendazole—TUBA1A—Pathogenic Escherichia coli infection—CDH1—head and neck cancer	0.000224	0.022	CbGpPWpGaD
Albendazole—CYP1A1—head—head and neck cancer	0.000218	0.00654	CbGeAlD
Albendazole—Leukopenia—Hydroxyurea—head and neck cancer	0.000216	0.0199	CcSEcCtD
Albendazole—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000213	0.0209	CbGpPWpGaD
Albendazole—Thrombocytopenia—Vinblastine—head and neck cancer	0.000211	0.0194	CcSEcCtD
Albendazole—Agranulocytosis—Fluorouracil—head and neck cancer	0.000207	0.0191	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000204	0.0188	CcSEcCtD
Albendazole—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000194	0.0191	CbGpPWpGaD
Albendazole—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000193	0.019	CbGpPWpGaD
Albendazole—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000193	0.0177	CcSEcCtD
Albendazole—Liver function test abnormal—Docetaxel—head and neck cancer	0.000192	0.0177	CcSEcCtD
Albendazole—Skin disorder—Hydroxyurea—head and neck cancer	0.000191	0.0176	CcSEcCtD
Albendazole—TUBA1A—Parkin-Ubiquitin Proteasomal System pathway—CASP8—head and neck cancer	0.000187	0.0184	CbGpPWpGaD
Albendazole—CYP1A1—Estrogen metabolism—GSTM1—head and neck cancer	0.000184	0.0181	CbGpPWpGaD
Albendazole—ABCB1—epithelium—head and neck cancer	0.000182	0.00547	CbGeAlD
Albendazole—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000176	0.0162	CcSEcCtD
Albendazole—Alopecia—Fluorouracil—head and neck cancer	0.000176	0.0162	CcSEcCtD
Albendazole—Pancytopenia—Docetaxel—head and neck cancer	0.000171	0.0157	CcSEcCtD
Albendazole—Abdominal pain—Vinblastine—head and neck cancer	0.000171	0.0157	CcSEcCtD
Albendazole—Neutropenia—Docetaxel—head and neck cancer	0.000168	0.0155	CcSEcCtD
Albendazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000164	0.0161	CbGpPWpGaD
Albendazole—ABCB1—trachea—head and neck cancer	0.000161	0.00484	CbGeAlD
Albendazole—Hypersensitivity—Vinblastine—head and neck cancer	0.000159	0.0146	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000159	0.0146	CcSEcCtD
Albendazole—Body temperature increased—Hydroxyurea—head and neck cancer	0.000156	0.0143	CcSEcCtD
Albendazole—Leukopenia—Fluorouracil—head and neck cancer	0.000155	0.0143	CcSEcCtD
Albendazole—CYP1A1—lymph node—head and neck cancer	0.000152	0.00458	CbGeAlD
Albendazole—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000152	0.014	CcSEcCtD
Albendazole—Agranulocytosis—Docetaxel—head and neck cancer	0.00015	0.0138	CcSEcCtD
Albendazole—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000149	0.0147	CbGpPWpGaD
Albendazole—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000145	0.0133	CcSEcCtD
Albendazole—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.000144	0.0142	CbGpPWpGaD
Albendazole—Hepatitis—Docetaxel—head and neck cancer	0.000144	0.0132	CcSEcCtD
Albendazole—Dizziness—Vinblastine—head and neck cancer	0.000143	0.0131	CcSEcCtD
Albendazole—Urinary tract disorder—Docetaxel—head and neck cancer	0.000142	0.0131	CcSEcCtD
Albendazole—Urethral disorder—Docetaxel—head and neck cancer	0.000141	0.013	CcSEcCtD
Albendazole—ABCB1—lymphoid tissue—head and neck cancer	0.00014	0.00421	CbGeAlD
Albendazole—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000139	0.0128	CcSEcCtD
Albendazole—Vomiting—Vinblastine—head and neck cancer	0.000137	0.0126	CcSEcCtD
Albendazole—Erythema multiforme—Docetaxel—head and neck cancer	0.000136	0.0125	CcSEcCtD
Albendazole—TUBB4B—Pathogenic Escherichia coli infection—CDH1—head and neck cancer	0.000135	0.0133	CbGpPWpGaD
Albendazole—Headache—Vinblastine—head and neck cancer	0.000135	0.0124	CcSEcCtD
Albendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000131	0.0129	CbGpPWpGaD
Albendazole—Dizziness—Hydroxyurea—head and neck cancer	0.00013	0.012	CcSEcCtD
Albendazole—Immune system disorder—Docetaxel—head and neck cancer	0.00013	0.012	CcSEcCtD
Albendazole—Nausea—Vinblastine—head and neck cancer	0.000128	0.0118	CcSEcCtD
Albendazole—ABCB1—thyroid gland—head and neck cancer	0.000127	0.00383	CbGeAlD
Albendazole—Alopecia—Docetaxel—head and neck cancer	0.000127	0.0117	CcSEcCtD
Albendazole—Vomiting—Hydroxyurea—head and neck cancer	0.000125	0.0115	CcSEcCtD
Albendazole—Rash—Hydroxyurea—head and neck cancer	0.000124	0.0114	CcSEcCtD
Albendazole—Dermatitis—Hydroxyurea—head and neck cancer	0.000124	0.0114	CcSEcCtD
Albendazole—Headache—Hydroxyurea—head and neck cancer	0.000123	0.0113	CcSEcCtD
Albendazole—TUBA1A—Cell Cycle, Mitotic—CCNA1—head and neck cancer	0.000123	0.0121	CbGpPWpGaD
Albendazole—CYP1A1—Oxidative Stress—SOD2—head and neck cancer	0.000123	0.0121	CbGpPWpGaD
Albendazole—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000122	0.012	CbGpPWpGaD
Albendazole—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.000117	0.0115	CbGpPWpGaD
Albendazole—CYP1A1—Oxidative Stress—GPX1—head and neck cancer	0.000117	0.0115	CbGpPWpGaD
Albendazole—Nausea—Hydroxyurea—head and neck cancer	0.000117	0.0108	CcSEcCtD
Albendazole—ABCB1—head—head and neck cancer	0.000113	0.0034	CbGeAlD
Albendazole—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—CASP8—head and neck cancer	0.000113	0.0111	CbGpPWpGaD
Albendazole—Urticaria—Fluorouracil—head and neck cancer	0.000113	0.0104	CcSEcCtD
Albendazole—Leukopenia—Docetaxel—head and neck cancer	0.000112	0.0103	CcSEcCtD
Albendazole—Body temperature increased—Fluorouracil—head and neck cancer	0.000112	0.0103	CcSEcCtD
Albendazole—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000111	0.0109	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—CCNA1—head and neck cancer	0.00011	0.0108	CbGpPWpGaD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000106	0.00975	CcSEcCtD
Albendazole—CYP1A1—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000105	0.0103	CbGpPWpGaD
Albendazole—Hypersensitivity—Fluorouracil—head and neck cancer	0.000104	0.00961	CcSEcCtD
Albendazole—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.000102	0.0101	CbGpPWpGaD
Albendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000101	0.00992	CbGpPWpGaD
Albendazole—Thrombocytopenia—Docetaxel—head and neck cancer	0.0001	0.00921	CcSEcCtD
Albendazole—Skin disorder—Docetaxel—head and neck cancer	9.93e-05	0.00914	CcSEcCtD
Albendazole—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	9.83e-05	0.00967	CbGpPWpGaD
Albendazole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	9.43e-05	0.00928	CbGpPWpGaD
Albendazole—Dizziness—Fluorouracil—head and neck cancer	9.37e-05	0.00862	CcSEcCtD
Albendazole—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	9.06e-05	0.00891	CbGpPWpGaD
Albendazole—Vomiting—Fluorouracil—head and neck cancer	9.01e-05	0.00829	CcSEcCtD
Albendazole—Rash—Fluorouracil—head and neck cancer	8.93e-05	0.00822	CcSEcCtD
Albendazole—Dermatitis—Fluorouracil—head and neck cancer	8.92e-05	0.00821	CcSEcCtD
Albendazole—Headache—Fluorouracil—head and neck cancer	8.87e-05	0.00817	CcSEcCtD
Albendazole—TUBA1A—Cell Cycle—RAD51—head and neck cancer	8.83e-05	0.00869	CbGpPWpGaD
Albendazole—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	8.59e-05	0.00845	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—GRP—head and neck cancer	8.57e-05	0.00843	CbGpPWpGaD
Albendazole—Nausea—Fluorouracil—head and neck cancer	8.41e-05	0.00775	CcSEcCtD
Albendazole—Gastrointestinal pain—Docetaxel—head and neck cancer	8.36e-05	0.0077	CcSEcCtD
Albendazole—Abdominal pain—Docetaxel—head and neck cancer	8.08e-05	0.00744	CcSEcCtD
Albendazole—Body temperature increased—Docetaxel—head and neck cancer	8.08e-05	0.00744	CcSEcCtD
Albendazole—ABCB1—lymph node—head and neck cancer	7.92e-05	0.00238	CbGeAlD
Albendazole—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	7.89e-05	0.00776	CbGpPWpGaD
Albendazole—CYP1A1—Arachidonic acid metabolism—GPX1—head and neck cancer	7.78e-05	0.00766	CbGpPWpGaD
Albendazole—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	7.6e-05	0.00747	CbGpPWpGaD
Albendazole—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	7.59e-05	0.00747	CbGpPWpGaD
Albendazole—Hypersensitivity—Docetaxel—head and neck cancer	7.53e-05	0.00693	CcSEcCtD
Albendazole—TUBB4B—Transmembrane transport of small molecules—ATP7B—head and neck cancer	7.44e-05	0.00732	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CCNA1—head and neck cancer	7.42e-05	0.0073	CbGpPWpGaD
Albendazole—CYP1A1—PPARA activates gene expression—YAP1—head and neck cancer	7.29e-05	0.00717	CbGpPWpGaD
Albendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—YAP1—head and neck cancer	7.13e-05	0.00702	CbGpPWpGaD
Albendazole—Dizziness—Docetaxel—head and neck cancer	6.76e-05	0.00622	CcSEcCtD
Albendazole—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	6.69e-05	0.00659	CbGpPWpGaD
Albendazole—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	6.68e-05	0.00657	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CCNA1—head and neck cancer	6.64e-05	0.00653	CbGpPWpGaD
Albendazole—Vomiting—Docetaxel—head and neck cancer	6.5e-05	0.00598	CcSEcCtD
Albendazole—Rash—Docetaxel—head and neck cancer	6.45e-05	0.00593	CcSEcCtD
Albendazole—Dermatitis—Docetaxel—head and neck cancer	6.44e-05	0.00593	CcSEcCtD
Albendazole—Headache—Docetaxel—head and neck cancer	6.4e-05	0.0059	CcSEcCtD
Albendazole—CYP1A1—Biological oxidations—NAT2—head and neck cancer	6.13e-05	0.00603	CbGpPWpGaD
Albendazole—Nausea—Docetaxel—head and neck cancer	6.07e-05	0.00559	CcSEcCtD
Albendazole—CYP1A1—Metapathway biotransformation—NAT2—head and neck cancer	6.04e-05	0.00594	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—TYMS—head and neck cancer	5.93e-05	0.00583	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—RAD51—head and neck cancer	5.33e-05	0.00525	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—TYMS—head and neck cancer	5.3e-05	0.00522	CbGpPWpGaD
Albendazole—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	5.25e-05	0.00517	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	5.25e-05	0.00517	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	5.25e-05	0.00517	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—GRP—head and neck cancer	5.17e-05	0.00509	CbGpPWpGaD
Albendazole—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	4.96e-05	0.00488	CbGpPWpGaD
Albendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—head and neck cancer	4.91e-05	0.00483	CbGpPWpGaD
Albendazole—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	4.91e-05	0.00483	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	4.9e-05	0.00482	CbGpPWpGaD
Albendazole—CYP1A1—Arachidonic acid metabolism—PTGS2—head and neck cancer	4.58e-05	0.00451	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	4.54e-05	0.00447	CbGpPWpGaD
Albendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	4.25e-05	0.00418	CbGpPWpGaD
Albendazole—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	4.19e-05	0.00412	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	4.11e-05	0.00405	CbGpPWpGaD
Albendazole—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	4.05e-05	0.00399	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—NAT2—head and neck cancer	3.91e-05	0.00384	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	3.86e-05	0.0038	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	3.85e-05	0.00379	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	3.74e-05	0.00368	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—TYMS—head and neck cancer	3.58e-05	0.00352	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	3.47e-05	0.00342	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	3.47e-05	0.00342	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	3.47e-05	0.00342	CbGpPWpGaD
Albendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	3.44e-05	0.00339	CbGpPWpGaD
Albendazole—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	3.3e-05	0.00324	CbGpPWpGaD
Albendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	3.28e-05	0.00322	CbGpPWpGaD
Albendazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	3.23e-05	0.00318	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—TYMS—head and neck cancer	3.2e-05	0.00315	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	3.12e-05	0.00307	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—CASP8—head and neck cancer	3.11e-05	0.00306	CbGpPWpGaD
Albendazole—CYP1A1—Biological oxidations—GSTM1—head and neck cancer	3.03e-05	0.00298	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—NAT2—head and neck cancer	3.01e-05	0.00297	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—CCND1—head and neck cancer	2.99e-05	0.00294	CbGpPWpGaD
Albendazole—CYP1A1—Metapathway biotransformation—GSTM1—head and neck cancer	2.98e-05	0.00294	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	2.97e-05	0.00292	CbGpPWpGaD
Albendazole—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	2.92e-05	0.00287	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	2.89e-05	0.00285	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	2.79e-05	0.00274	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—CCND1—head and neck cancer	2.67e-05	0.00263	CbGpPWpGaD
Albendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	2.66e-05	0.00261	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—UROD—head and neck cancer	2.52e-05	0.00248	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—MAPK3—head and neck cancer	2.46e-05	0.00242	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	2.46e-05	0.00242	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—IL2—head and neck cancer	2.35e-05	0.00231	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—MAPK1—head and neck cancer	2.34e-05	0.00231	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	2.31e-05	0.00227	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	2.26e-05	0.00222	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	2.25e-05	0.00221	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	2.21e-05	0.00218	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	2.21e-05	0.00218	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	2.21e-05	0.00218	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—MAPK3—head and neck cancer	2.2e-05	0.00217	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—MAPK1—head and neck cancer	2.1e-05	0.00206	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—UROD—head and neck cancer	2.01e-05	0.00198	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	2e-05	0.00197	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.96e-05	0.00193	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	1.93e-05	0.0019	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	1.9e-05	0.00187	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	1.83e-05	0.0018	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	1.8e-05	0.00177	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CCND1—head and neck cancer	1.8e-05	0.00177	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	1.78e-05	0.00175	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—TP53—head and neck cancer	1.76e-05	0.00173	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CCND1—head and neck cancer	1.61e-05	0.00159	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—UROD—head and neck cancer	1.61e-05	0.00158	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	1.54e-05	0.00151	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	1.49e-05	0.00146	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—MAPK3—head and neck cancer	1.49e-05	0.00146	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	1.47e-05	0.00145	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	1.47e-05	0.00144	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—MAPK1—head and neck cancer	1.41e-05	0.00139	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	1.41e-05	0.00139	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	1.39e-05	0.00137	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—MAPK3—head and neck cancer	1.33e-05	0.00131	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	1.32e-05	0.0013	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—MAPK1—head and neck cancer	1.27e-05	0.00124	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	1.25e-05	0.00123	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.25e-05	0.00123	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—UROD—head and neck cancer	1.24e-05	0.00122	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	1.13e-05	0.00111	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.11e-05	0.00109	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	1.09e-05	0.00107	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—TP53—head and neck cancer	1.06e-05	0.00104	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NAT2—head and neck cancer	1.05e-05	0.00103	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	9.87e-06	0.000971	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	9.33e-06	0.000918	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—DPYD—head and neck cancer	9.19e-06	0.000904	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	8.88e-06	0.000874	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	8.88e-06	0.000874	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—YAP1—head and neck cancer	8.72e-06	0.000857	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NAT2—head and neck cancer	8.37e-06	0.000823	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	7.71e-06	0.000758	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	7.46e-06	0.000733	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—DPYD—head and neck cancer	7.34e-06	0.000722	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	7.09e-06	0.000698	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	7.02e-06	0.000691	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—YAP1—head and neck cancer	6.96e-06	0.000685	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NAT2—head and neck cancer	6.68e-06	0.000657	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.55e-06	0.000644	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	6.3e-06	0.000619	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—DPYD—head and neck cancer	5.86e-06	0.000576	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.71e-06	0.000562	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—YAP1—head and neck cancer	5.56e-06	0.000547	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—TYMS—head and neck cancer	5.23e-06	0.000515	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTM1—head and neck cancer	5.17e-06	0.000509	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NAT2—head and neck cancer	5.15e-06	0.000507	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GPX1—head and neck cancer	4.95e-06	0.000487	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—DPYD—head and neck cancer	4.52e-06	0.000445	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—YAP1—head and neck cancer	4.29e-06	0.000422	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—TYMS—head and neck cancer	4.18e-06	0.000411	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.18e-06	0.000411	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTM1—head and neck cancer	4.13e-06	0.000406	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.03e-06	0.000396	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GPX1—head and neck cancer	3.96e-06	0.000389	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP1A1—head and neck cancer	3.92e-06	0.000385	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.64e-06	0.000358	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—TYMS—head and neck cancer	3.34e-06	0.000328	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTM1—head and neck cancer	3.3e-06	0.000325	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GPX1—head and neck cancer	3.16e-06	0.000311	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP1A1—head and neck cancer	3.13e-06	0.000308	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTGS2—head and neck cancer	2.92e-06	0.000287	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—TYMS—head and neck cancer	2.58e-06	0.000253	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.57e-06	0.000253	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.55e-06	0.00025	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTEN—head and neck cancer	2.54e-06	0.00025	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GPX1—head and neck cancer	2.44e-06	0.00024	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.41e-06	0.000237	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTGS2—head and neck cancer	2.33e-06	0.000229	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTEN—head and neck cancer	2.03e-06	0.0002	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.86e-06	0.000183	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CA—head and neck cancer	1.79e-06	0.000177	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTEN—head and neck cancer	1.62e-06	0.00016	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—AKT1—head and neck cancer	1.47e-06	0.000144	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.44e-06	0.000141	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.43e-06	0.000141	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTEN—head and neck cancer	1.25e-06	0.000123	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AKT1—head and neck cancer	1.17e-06	0.000115	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.14e-06	0.000113	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AKT1—head and neck cancer	9.35e-07	9.19e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CA—head and neck cancer	8.83e-07	8.69e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AKT1—head and neck cancer	7.21e-07	7.1e-05	CbGpPWpGaD
